Harlan Weisman is the CEO of TFF Pharmaceuticals, a clinical-stage biopharmaceutical company focused on drug products utilizing its Thin Film Freezing (TFF).
Harlan Weisman is the CEO of TFF Pharmaceuticals, a clinical-stage biopharmaceutical company focused on drug products utilizing its Thin Film Freezing (TFF) technology. Under his leadership, the company is advancing its Tacrolimus Inhalation Powder (TFF TAC) through Phase 2 trials for lung transplant recipients. TFF Pharmaceuticals recently secured $6.0 million in financing in 2024 to support the development of TFF TAC.
Full founder directory · Investor directory · Company funding database · Fundraising library